LIST OF HUMAN AND ANIMAL PATHOGENS AND TOXINS FOR EXPORT CONTROL
- African horse sickness virus
- African swine fever virus
- Andes virus
- Avian influenza virus
- Bluetongue virus
- Chapare virus
- Chikungunya virus
- Choclo virus
- Classical swine fever virus (Hog cholera virus)
- Crimean-Congo hemorrhagic fever virus
- Dobrava-Belgrade virus
- Eastern equine encephalitis virus
- Ebolavirus: all members of the Ebolavirus genus
- Foot-and-mouth disease virus
- Goatpox virus
- Guanarito virus
- Hantaan virus
- Hendra virus (Equine morbillivirus)
- Japanese encephalitis virus
- Junin virus
- Kyasanur Forest disease virus
- Laguna Negra virus
- Lassa virus
- Louping ill virus
- Lujo virus
- Lumpy skin disease virus
- Lymphocytic choriomeningitis virus
- Machupo virus
- Marburgvirus: all members of the Marburgvirus genus
- Monkeypox virus
- Murray Valley encephalitis virus
- Newcastle disease virus
- Nipah virus
- Omsk hemorrhagic fever virus
- Oropouche virus
- Peste-des-petits-ruminants virus
- Porcine Teschovirus
- Powassan virus
- Rabies virus and other members of the Lyssavirus genus
- Reconstructed 1918 influenza virus
- Rift Valley fever virus
- Rinderpest virus
- Rocio virus
- Sabia virus
- Seoul virus
- Severe acute respiratory syndrome-related coronavirus (SARS-related coronavirus)
- Sheeppox virus
- Sin Nombre virus
- St. Louis encephalitis virus
- Suid herpesvirus 1 (Pseudorabies virus; Aujeszky's disease)
- Swine vesicular disease virus
- Tick-borne encephalitis virus (Far Eastern subtype)
- Variola virus
- Venezuelan equine encephalitis virus
- Vesicular stomatitis virus
- Western equine encephalitis virus
- Yellow fever virus
- Bacillus anthracis
- Brucella abortus
- Brucella melitensis
- Brucella suis
- Burkholderia mallei (Pseudomonas mallei)
- Burkholderia pseudomallei (Pseudomonas pseudomallei)
- Chlamydia psittaci (Chlamydophila psittaci)
- Clostridium argentinense (formerly known as Clostridium botulinum Type G), botulinum neurotoxin producing strains
- Clostridium baratii, botulinum neurotoxin producing strains
- Clostridium botulinum
- Clostridium butyricum, botulinum neurotoxin producing strains
- Clostridium perfringens, epsilon toxin producing types
- Coxiella burnetii
- Francisella tularensis
- Mycoplasma capricolum subspecies capripneumoniae (“strain F38”)
- Mycoplasma mycoides subspecies mycoides SC (small colony)
- Rickettsia prowazekii
- Salmonella enterica subspecies enterica serovar Typhi (Salmonella typhi)
- Shiga toxin producing Escherichia coli (STEC) of serogroups O26, O45, O103, O104, O111, O121, O145, O157, and other shiga toxin producing serogroups
- Shigella dysenteriae
- Vibrio cholerae
- Yersinia pestis
Toxins as follows and subunits thereof: 
- Botulinum toxins
- Cholera toxin
- Clostridium perfringens alpha, beta 1, beta 2, epsilon and iota toxins
- Conotoxins 
- HT-2 toxin
- Microcystins (Cyanoginosins)
- Shiga toxins (shiga-like toxins, verotoxins, and verocytotoxins)
- Staphylococcus aureus enterotoxins, hemolysin alpha toxin, and toxic shock syndrome toxin (formerly known as Staphylococcus enterotoxin F)
- T-2 toxin
- Viscumin (Viscum album lectin 1)
- Coccidioides immitis
- Coccidioides posadasii
 An agent/pathogen is covered by this list except when it is in the form of a vaccine. A vaccine is a medicinal product in a pharmaceutical formulation licensed by, or having marketing or clinical trial authorisation from, the regulatory authorities of either the country of manufacture or of use, which is intended to stimulate a protective immunological response in humans or animals in order to prevent disease in those to whom or to which it is administered.
Biological agents and pathogens are controlled when they are an isolated live culture of a pathogen agent, or a preparation of a toxin agent which has been isolated or extracted from any source, or material including living material which has been deliberately inoculated or contaminated with the agent. Isolated live cultures of a pathogen agent include live cultures in dormant form or in dried preparations, whether the agent is natural, enhanced or modified.
 This includes only those Avian influenza viruses of high pathogenicity as defined by the World Organization for Animal Health (OIE), the European Union (EU), or competent national regulatory bodies.
 It is understood that limiting this control to epsilon toxin-producing strains of Clostridium perfringens therefore exempts from control the transfer of other Clostridium perfringens strains to be used as positive control cultures for food testing and quality control.
 Shiga toxin producing Escherichia coli (STEC) includes inter alia enterohaemorrhagic E. coli (EHEC), verotoxin producing E. coli (VTEC) or verocytotoxin producing E. coli (VTEC).
 Excluding immunotoxins
 Excluding botulinum toxins and conotoxins in product form meeting all of the following criteria:
- are pharmaceutical formulations designed for testing and human administration in the treatment of medical conditions;
- are pre-packaged for distribution as clinical or medical products; and
- are authorised by a state authority to be marketed as clinical or medical products .
- Clostridium tetani
- Legionella pneumophila
- Yersinia pseudotuberculosis
- Other strains of Clostridium species that produce botulinum neurotoxin
- Fusarium langsethiae
- Fusarium sporotrichioides
 Biological agents are controlled when they are an isolated live culture of a pathogen agent, or a preparation of a toxin agent which has been isolated or extracted from any source, or material including living material which has been deliberately inoculated or contaminated with the agent. Isolated live cultures of a pathogen agent include live cultures in dormant form or in dried preparations, whether the agent is natural, enhanced or modified.
An agent is covered by this list except when it is in the form of a vaccine. A vaccine is a medicinal product in a pharmaceutical formulation licensed by, or having marketing or clinical trial authorisation from, the regulatory authorities of either the country of manufacture or of use, which is intended to stimulate a protective immunological response in humans or animals in order to prevent disease in those to whom or to which it is administered.
 The Australia Group recognizes that this organism is ubiquitous, but, as it has been acquired in the past as part of biological warfare programs, it is worthy of special caution.
 It is the intent of Australia Group members to add to the control list strains of species of Clostridium identified as producing botulinum neurotoxin.
Genetic Elements and Genetically-modified Organisms:
Any genetically-modified organism1 which contains, or genetic element2 that codes for:
- any gene or genes specific to any listed virus; or
- any gene or genes specific to any listed bacterium3 or fungus, and which
- in itself or through its transcribed or translated products represents a significant hazard to human, animal or plant health, or
- could endow or enhance pathogenicity4; or
- any listed toxins or their sub-units.
- Genetically-modified organisms include organisms in which the nucleic acid sequences have been created or altered by deliberate molecular manipulation.
- Genetic elements include, inter alia: chromosomes, genomes, plasmids, transposons, vectors, and inactivated organisms containing recoverable nucleic acid fragments, whether genetically modified or unmodified, or chemically synthesized in whole or in part. For the purposes of the genetic elements control, nucleic acids from an inactivated organism, virus, or sample are considered 'recoverable' if the inactivation and preparation of the material is intended or known to facilitate isolation, purification, amplification, detection, or identification of nucleic acids.
- These controls do not apply to nucleic acid sequences of shiga toxin producing Escherichia coli of serogroups O26, O45, O103, O104, O111, O121, O145, O157, and other shiga toxin producing serogroups, other than those genetic elements coding for shiga toxin, or for its subunits.
- 'Endow or enhance pathogenicity' is defined as when the insertion or integration of the nucleic acid sequence or sequences is/are likely to enable or increase a recipient organism's ability to be used to deliberately cause disease or death. This might include alterations to, inter alia: virulence, transmissibility, stability, route of infection, host range, reproducibility, ability to evade or suppress host immunity, resistance to medical countermeasures, or detectability.